Meningitis/Encephalitis
8
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (8)
MUSic Therapy In Complex Specialist Neurorehabilitation
Recovery Trajectory for Coma and Disorders of Consciousness
Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study
Brazil ICU Encephalitis Surveillance
A Diagnostic Test on DeepDoc-an AI-based Decision Support System
Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel